{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:57:13Z","timestamp":1783414633323,"version":"3.54.6"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00428-025-04318-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:10:08Z","timestamp":1766707808000},"page":"721-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An update on the role of SMARCA4 deficiency in gynecological neoplasms: how and where"],"prefix":"10.1007","volume":"488","author":[{"given":"Livia","family":"Maccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bragantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-7560","authenticated-orcid":false,"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"4318_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-3-031-45654-1_7","volume":"190","author":"VT Nguyen","year":"2023","unstructured":"Nguyen VT, Tessema M, Weissman BE (2023) The SWI\/SNF complex: a frequently mutated chromatin remodeling complex in cancer. Cancer Treat Res 190:211\u2013244. https:\/\/doi.org\/10.1007\/978-3-031-45654-1_7","journal-title":"Cancer Treat Res"},{"issue":"12","key":"4318_CR2","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-21-0433","volume":"20","author":"K Mardinian","year":"2021","unstructured":"Mardinian K, Adashek JJ, Botta GP, Kato S, Kurzrock R (2021) SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy. Mol Cancer Ther 20(12):2341\u20132351. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0433","journal-title":"Mol Cancer Ther"},{"key":"4318_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.762598","volume":"12","author":"L Peng","year":"2021","unstructured":"Peng L, Li J, Wu J, Xu B, Wang Z, Giamas G, Stebbing J, Yu Z (2021) A pan-cancer analysis of SMARCA4 alterations in human cancers. Front Immunol 12:762598. https:\/\/doi.org\/10.3389\/fimmu.2021.762598","journal-title":"Front Immunol"},{"issue":"2","key":"4318_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4161\/epi.3.2.6153","volume":"3","author":"PP Medina","year":"2008","unstructured":"Medina PP, Sanchez-Cespedes M (2008) Involvement of the chromatin-remodeling factor BRG1\/SMARCA4 in human cancer. Epigenetics 3(2):64\u201368. https:\/\/doi.org\/10.4161\/epi.3.2.6153","journal-title":"Epigenetics"},{"issue":"5","key":"4318_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.anndiagpath.2015.06.001","volume":"19","author":"A Agaimy","year":"2015","unstructured":"Agaimy A, Thiel F, Hartmann A, Fukunaga M (2015) SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases. Ann Diagn Pathol 19(5):283\u2013287. https:\/\/doi.org\/10.1016\/j.anndiagpath.2015.06.001","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"4318_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","volume":"31","author":"DL Kolin","year":"2018","unstructured":"Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, Crum CP, Howitt BE (2018) SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol 31(9):1442\u20131456. https:\/\/doi.org\/10.1038\/s41379-018-0049-z","journal-title":"Mod Pathol"},{"issue":"3","key":"4318_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1053\/j.semdp.2020.08.003","volume":"38","author":"WG McCluggage","year":"2021","unstructured":"McCluggage WG, Stewart CJR (2021) SWI\/SNF-deficient malignancies of the female genital tract. Semin Diagn Pathol 38(3):199\u2013211. https:\/\/doi.org\/10.1053\/j.semdp.2020.08.003","journal-title":"Semin Diagn Pathol"},{"key":"4318_CR8","doi-asserted-by":"publisher","unstructured":"Kommoss FKF, Schmidt D, Kommoss F, Tessier-Cloutier B (2023) Small-cell carcinoma of the ovary hypercalcaemic type shows a wild-type immunohistochemical staining pattern of p53. Histopathology 83:154\u2013156. https:\/\/doi.org\/10.1111\/his.14926","DOI":"10.1111\/his.14926"},{"issue":"1","key":"4318_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13000-023-01347-3","volume":"18","author":"J Gao","year":"2023","unstructured":"Gao J, Fan R, Chen D, Hou J, Chen H, Lu M (2023) Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma. Diagn Pathol 18(1):62. https:\/\/doi.org\/10.1186\/s13000-023-01347-3","journal-title":"Diagn Pathol"},{"issue":"2","key":"4318_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","volume":"44","author":"DL Kolin","year":"2020","unstructured":"Kolin DL, Quick CM, Dong F, Fletcher CDM, Stewart CJR, Soma A, Hornick JL, Nucci MR, Howitt BE (2020) SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities. Am J Surg Pathol 44(2):263\u2013270. https:\/\/doi.org\/10.1097\/PAS.0000000000001375","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"4318_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100374","volume":"37","author":"B Tessier-Cloutier","year":"2024","unstructured":"Tessier-Cloutier B, Kommoss FKF, Kolin DL, N\u011bmejcov\u00e1 K, Smith D, Pors J, Stewart CJR, McCluggage WG, Foulkes WD, von Deimling A, K\u00f6bel M, Lee CH (2024) Dedifferentiated and undifferentiated ovarian carcinoma: an aggressive and molecularly distinct ovarian tumor characterized by frequent SWI\/SNF complex inactivation. Mod Pathol 37(1):100374. https:\/\/doi.org\/10.1016\/j.modpat.2023.100374","journal-title":"Mod Pathol"},{"issue":"8","key":"4318_CR12","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/annonc\/mdz160","volume":"1","author":"C Henon","year":"2019","unstructured":"Henon C, Blay JY, Massard C, Mir O, Bahleda R, Dumont S, Postel-Vinay S, Adam J, Soria JC, Le Cesne A (2019) Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor. Ann Oncol 1(8):1401\u20131403. https:\/\/doi.org\/10.1093\/annonc\/mdz160","journal-title":"Ann Oncol"},{"issue":"7","key":"4318_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/his.13177","volume":"70","author":"WG McCluggage","year":"2017","unstructured":"McCluggage WG, Witkowski L, Clarke BA, Foulkes WD (2017) Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm. Histopathology 70(7):1147\u20131154. https:\/\/doi.org\/10.1111\/his.13177","journal-title":"Histopathology"},{"issue":"12","key":"4318_CR14","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-18-0348","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen SY, Colborne S, Lambert G, Shin CY, Santos ND, Orlando KA, Lang JD, Hendricks WPD, Bally MB, Karnezis AN, Hass R, Underhill TM, Morin GB, Trent JM, Weissman BE, Huntsman DG (2018) Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type. Mol Cancer Ther 17(12):2767\u20132779. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0348","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"4318_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","volume":"10","author":"Y Xue","year":"2019","unstructured":"Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, Jung S, Camilleri-Broet S, Gonzalez AV, Guiot MC, Lockwood WW, Spicer JD, Agaimy A, Pastor WA, Dostie J, Rak J, Foulkes WD, Huang S (2019) SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer. Nat Commun 10(1):557","journal-title":"Nat Commun"},{"issue":"8","key":"4318_CR16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-17-1928","volume":"24","author":"JD Lang","year":"2018","unstructured":"Lang JD, Hendricks WPD, Orlando KA, Yin H, Kiefer J, Ramos P, Sharma R, Pirrotte P, Raupach EA, Sereduk C, Tang N, Liang WS, Washington M, Facista SJ, Zismann VL, Cousins EM, Major MB, Wang Y, Karnezis AN, Sekulic A, Hass R, Vanderhyden BC, Nair P, Weissman BE, Huntsman DG, Trent JM (2018) Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multikinase inhibition. Clin Cancer Res 24(8):1932\u20131943","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4318_CR17","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1158\/1078-0432.CCR-15-1468","volume":"22","author":"EH Bell","year":"2016","unstructured":"Bell EH, Chakraborty AR, Mo X, Liu Z, Shilo K, Kirste S, Stegmaier P, McNulty M, Karachaliou N, Rosell R, Bepler G, Carbone DP, Chakravarti A (2016) SMARCA4\/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer. Clin Cancer Res. 22(10):2396\u20132404. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1468","journal-title":"Clin Cancer Res."},{"issue":"1","key":"4318_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19402-8","volume":"11","author":"TM Fernando","year":"2020","unstructured":"Fernando TM, Piskol R, Bainer R, Sokol ES, Trabucco SE, Zhang Q, Trinh H, Maund S, Kschonsak M, Chaudhuri S, Modrusan Z, Januario T, Yauch RL (2020) Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients. Nat Commun 11(1):5551. https:\/\/doi.org\/10.1038\/s41467-020-19402-8","journal-title":"Nat Commun"},{"issue":"3","key":"4318_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101585","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Chen HC, Yang L, Yang G, Liang L, Yang Y, Tang H, Bao H, Wu X, Shao Y, An G, Wang Y (2023) Mutational landscape of SWI\/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients. ESMO Open 8(3):101585. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101585","journal-title":"ESMO Open"},{"issue":"6","key":"4318_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100183","volume":"36","author":"AJ Neil","year":"2023","unstructured":"Neil AJ, Zhao L, Isidro RA, Srivastava A, Cleary JM, Dong F (2023) SMARCA4 mutations in carcinomas of the esophagus, esophagogastric junction, and stomach. Mod Pathol 36(6):100183. https:\/\/doi.org\/10.1016\/j.modpat.2023.100183","journal-title":"Mod Pathol"},{"issue":"1","key":"4318_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-023-00367-y","volume":"7","author":"X Zeng","year":"2023","unstructured":"Zeng X, Yao B, Liu J, Gong GW, Liu M, Li J, Pan HF, Li Q, Yang D, Lu P, Wu D, Xu P, Chen B, Chen P, Zhang M, Zen K, Jing J, Huang DCS, Chen D, Jiang ZW, Zhao Q (2023) The SMARCA4R1157W mutation facilitates chromatin remodeling and confers PRMT1\/SMARCA4 inhibitors sensitivity in colorectal cancer. NPJ Precis Oncol 7(1):28","journal-title":"NPJ Precis Oncol"},{"key":"4318_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ygyno.2023.07.016","volume":"176","author":"NKY Wong","year":"2023","unstructured":"Wong NKY, Llaurado Fernandez M, Kommoss FKF, Praveen Kumar P, Kim H, Liu J, Zhang G, Coatham M, Lin YY, Haegert AM, Volik S, Le Bihan S, Collins CC, Fu Y, Postovit LM, von Deimling A, Wu R, Xue H, Wang Y, K\u00f6bel M, Carey MS, Lee CH (2023) Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A\/ARID1B co-inactivated dedifferentiated endometrial carcinoma. Gynecol Oncol 176:162\u2013172. https:\/\/doi.org\/10.1016\/j.ygyno.2023.07.016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4318_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2350\/14-07-1531-MISC.1","volume":"18","author":"ST Sredni","year":"2015","unstructured":"Sredni ST, Tomita T (2015) Rhabdoid tumor predisposition syndrome. Pediatr Dev Pathol 18(1):49\u201358. https:\/\/doi.org\/10.2350\/14-07-1531-MISC.1","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"4318_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.semdp.2020.05.005","volume":"38","author":"IM Schaefer","year":"2021","unstructured":"Schaefer IM, Hornick JL (2021) SWI\/SNF complex-deficient soft tissue neoplasms: an update. Semin Diagn Pathol 38(3):222\u2013231. https:\/\/doi.org\/10.1053\/j.semdp.2020.05.005","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"4318_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/PAS.0000000000000558","volume":"40","author":"N Conlon","year":"2016","unstructured":"Conlon N, Silva A, Guerra E, Jelinic P, Schlappe BA, Olvera N, Mueller JJ, Tornos C, Jungbluth AA, Young RH, Oliva E, Levine D, Soslow RA (2016) Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type. Am J Surg Pathol 40(3):395\u2013403. https:\/\/doi.org\/10.1097\/PAS.0000000000000558","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"4318_CR26","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/PAS.0000000000000475","volume":"39","author":"M Karanian-Philippe","year":"2015","unstructured":"Karanian-Philippe M, Velasco V, Longy M, Floquet A, Arnould L, Coindre JM, Le Naoures-M\u00e9ar C, Averous G, Guyon F, MacGrogan G, Croce S (2015) SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas. Am J Surg Pathol 39(9):1197\u20131205","journal-title":"Am J Surg Pathol"},{"key":"4318_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.anndiagpath.2016.10.006","volume":"26","author":"E Herpel","year":"2017","unstructured":"Herpel E, Rieker RJ, Dienemann H, Muley T, Meister M, Hartmann A, Warth A, Agaimy A (2017) SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol 26:47\u201351. https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.006","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"4318_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/his.13091","volume":"70","author":"P Ramalingam","year":"2017","unstructured":"Ramalingam P, Croce S, McCluggage WG (2017) Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology 70(3):359\u2013366. https:\/\/doi.org\/10.1111\/his.13091","journal-title":"Histopathology"},{"issue":"1","key":"4318_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00428-020-03011-3","volume":"478","author":"K Chatzopoulos","year":"2021","unstructured":"Chatzopoulos K, Boland JM (2021) Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors. Virchows Arch 478(1):21\u201330. https:\/\/doi.org\/10.1007\/s00428-020-03011-3","journal-title":"Virchows Arch"},{"issue":"11","key":"4318_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/PAS.0000000000002088","volume":"47","author":"J Mazibrada","year":"2023","unstructured":"Mazibrada J, Jayatunge N, Domecq C, Witkowski L, Croce S, Foulkes WD, McCluggage WG (2023) Unusual aspects of small cell carcinoma of the ovary of hypercalcaemic type: retained SMARCA4 immunohistochemical staining and positive staining with TLE1. Am J Surg Pathol 47(11):1261\u20131266. https:\/\/doi.org\/10.1097\/PAS.0000000000002088","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4318_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/his.12988","volume":"69","author":"BA Clarke","year":"2016","unstructured":"Clarke BA, Witkowski L, Ton Nu TN, Shaw PA, Gilks CB, Huntsman D, Karnezis AN, Sebire N, Lamovec J, Roth LM, Stewart CJ, Hasselblatt M, Foulkes WD, McCluggage WG (2016) Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics. Histopathology 69(5):727\u2013738","journal-title":"Histopathology"},{"key":"4318_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151721","volume":"52","author":"G Parikshaa","year":"2021","unstructured":"Parikshaa G, Ariba Z, Pranab D, Nalini G, Manish R, Vanita S, Bhavana R, Devi D, Ram S, Prema M, Arvind R, Radhika S (2021) Juvenile granulosa cell tumor of the ovary: a comprehensive clinicopathologic analysis of 15 cases. Ann Diagn Pathol 52:151721. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151721","journal-title":"Ann Diagn Pathol"},{"issue":"8","key":"4318_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/PAS.0000000000001687","volume":"45","author":"M Warnnissorn","year":"2021","unstructured":"Warnnissorn M, Watkins JC, Young RH (2021) Dysgerminoma of the ovary: an analysis of 140 cases emphasizing unusual microscopic findings and resultant diagnostic problems. Am J Surg Pathol 45(8):1009\u20131027. https:\/\/doi.org\/10.1097\/PAS.0000000000001687","journal-title":"Am J Surg Pathol"},{"key":"4318_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100788","volume":"37","author":"AK Baa","year":"2021","unstructured":"Baa AK, Rastogi S, Tripathy S, Shamim SA, Menon S (2021) Unfolding the rarity of SMARCA4 deficient uterine sarcoma (SDUS): a case report. Gynecol Oncol Rep 37:100788. https:\/\/doi.org\/10.1016\/j.gore.2021.100788","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"4318_CR35","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.modpat.2022","volume":"36","author":"FKF Kommoss","year":"2023","unstructured":"Kommoss FKF, Mar LM, Howitt BE, Hanley K, Turashvilli G, Buslei R, Irving JA, Dickson BC, Koelsche C, Sinn HP, Schirmacher P, von Deimling A, Chiang S, McCluggage WG, Croce S, Stewart CJR, Lee CH (2023) High-grade endometrial stromal sarcomas with YWHAE::NUTM2 gene fusion exhibit recurrent CDKN2A alterations and absence of p16 staining is a poor prognostic marker. Mod Pathol 36(3):100044. https:\/\/doi.org\/10.1016\/j.modpat.2022","journal-title":"Mod Pathol"},{"issue":"2","key":"4318_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PAS.0000000000001981","volume":"47","author":"B Boyraz","year":"2023","unstructured":"Boyraz B, Watkins JC, Young RH, Oliva E (2023) Uterine tumors resembling ovarian sex cord tumors: a clinicopathologic study of 75 cases emphasizing features predicting adverse outcome and differential diagnosis. Am J Surg Pathol 47(2):234\u2013247. https:\/\/doi.org\/10.1097\/PAS.0000000000001981","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"4318_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/PAS.0000000000001215","volume":"43","author":"P Cotzia","year":"2019","unstructured":"Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S (2019) Undifferentiated uterine sarcomas represent under-recognized high-grade endometrial stromal sarcomas. Am J Surg Pathol 43(5):662\u2013669. https:\/\/doi.org\/10.1097\/PAS.0000000000001215","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"4318_CR38","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/PAS.0000000000001265","volume":"43","author":"CH Lee","year":"2019","unstructured":"Lee CH, Kao YC, Lee WR, Hsiao YW, Lu TP, Chu CY, Lin YJ, Huang HY, Hsieh TH, Liu YR, Liang CW, Chen TW, Yip S, Lum A, Kuo KT, Jeng YM, Yu SC, Chung YC, Lee JC (2019) Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation. Am J Surg Pathol 43(7):928\u2013942. https:\/\/doi.org\/10.1097\/PAS.0000000000001265","journal-title":"Am J Surg Pathol"},{"issue":"22","key":"4318_CR39","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.3390\/jcm12227131","volume":"12","author":"M Ferrara","year":"2023","unstructured":"Ferrara M, Pecorino B, D\u2019Agate MG, Angelico G, Capoluongo ED, Malapelle U, Pepe F, Scollo P, Mereu L (2023) Uterine tumours resembling ovarian sex-cord tumors: a case report and review of the literature. J Clin Med 12(22):7131. https:\/\/doi.org\/10.3390\/jcm12227131","journal-title":"J Clin Med"},{"issue":"10","key":"4318_CR40","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","volume":"42","author":"JA Bennett","year":"2018","unstructured":"Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, Zhang L, Morales-Oyarvide V, Kiyokawa T, Zannoni GF, Carlson J, Slavik T, Tornos C, Antonescu CR, Oliva E (2018O) Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors. Am J Surg Pathol 42(10):1370\u20131383. https:\/\/doi.org\/10.1097\/PAS.0000000000001119","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4318_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2022.07.031","volume":"167","author":"S Croce","year":"2022","unstructured":"Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C (2022) Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecol Oncol 167(2):373\u2013389. https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.031","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4318_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ygyno.2021.02.029","volume":"161","author":"A Santoro","year":"2021","unstructured":"Santoro A, Angelico G, Travaglino A, Raffone A, Arciuolo D, D\u2019Alessandris N, Inzani F, Zannoni GF (2021) Clinico-pathological significance of TCGA classification and SWI\/SNF proteins expression in undifferentiated\/dedifferentiated endometrial carcinoma: a possible prognostic risk stratification. Gynecol Oncol 161(2):629\u2013635. https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.029","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4318_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/cjp2.188","volume":"7","author":"B Tessier-Cloutier","year":"2021","unstructured":"Tessier-Cloutier B, Coatham M, Carey M, Nelson GS, Hamilton S, Lum A, Soslow RA, Stewart CJ, Postovit LM, K\u00f6bel M, Lee CH (2021) SWI\/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma. J Pathol Clin Res 7(2):144\u2013153. https:\/\/doi.org\/10.1002\/cjp2.188","journal-title":"J Pathol Clin Res"},{"issue":"11","key":"4318_CR44","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cancers13112623","volume":"13","author":"A Santoro","year":"2021","unstructured":"Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, Valente M, D\u2019Alessandris N, Scaglione G, Fiorentino V, Raffone A, Zannoni GF (2021) New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP Guidelines. Cancers (Basel) 13(11):2623. https:\/\/doi.org\/10.3390\/cancers13112623","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4318_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijgo.13937","volume":"158","author":"A Travaglino","year":"2022","unstructured":"Travaglino A, Raffone A, Raimondo D, Arciuolo D, Angelico G, Valente M, Scaglione G, D\u2019alessandris N, Casadio P, Inzani F, Mollo A, Santoro A, Seracchioli R, Franco ZG (2022) Prognostic value of the TCGA molecular classification in uterine carcinosarcoma. Int J Gynaecol Obstet 158(1):13\u201320. https:\/\/doi.org\/10.1002\/ijgo.13937","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"4318_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/his.14110","volume":"77","author":"K Chaudet","year":"2020","unstructured":"Chaudet K, Kem M, Lerwill M, Young RH, Mino-Kenudson M, Agaimy A, McCluggage WG, Oliva E (2020) SWI\/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum. Histopathology 77(2):231\u2013239. https:\/\/doi.org\/10.1111\/his.14110","journal-title":"Histopathology"},{"issue":"5","key":"4318_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cllc.2022.03.005","volume":"23","author":"Y Shinno","year":"2022","unstructured":"Shinno Y, Yoshida A, Masuda K, Matsumoto Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Yamamoto N, Yatabe Y, Ohe Y (2022) Efficacy of immune checkpoint inhibitors in SMARCA4-deficient thoracic tumor. Clin Lung Cancer 23(5):386\u2013392. https:\/\/doi.org\/10.1016\/j.cllc.2022.03.005","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"4318_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02306-1","volume":"11","author":"K Yano","year":"2025","unstructured":"Yano K, Kato M, Endo S, Igarashi T, Wada R, Kohno T, Zimmermann A, Dahmen H, Zenke FT, Shiotani B (2025) PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells. Cell Death Discov 11(1):31. https:\/\/doi.org\/10.1038\/s41420-025-02306-1","journal-title":"Cell Death Discov"},{"issue":"6","key":"4318_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063237","volume":"25","author":"V Longo","year":"2024","unstructured":"Longo V, Catino A, Montrone M, Montagna ES, Pesola F, Marech I, Pizzutilo P, Nardone A, Perrone A, Gesualdo M, Galetta D (2024) Treatment of thoracic SMARCA4-deficient undifferentiated tumors: where we are and where we will go. Int J Mol Sci 25(6):3237. https:\/\/doi.org\/10.3390\/ijms25063237","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4318_CR50","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","volume":"24","author":"Y Lissanu Deribe","year":"2018","unstructured":"Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, Gao G, Mullinax RA, Khor T, Feng N, Lin YH, Wu CC, Reyes C, Peng Q, Robinson F, Inoue A, Kochat V, Liu CG, Asara JM, Moran C, Muller F, Wang J, Fang B, Papadimitrakopoulou V, Wistuba II, Rai K, Marszalek J, Futreal PA (2018) Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med 24(7):1047\u20131057. https:\/\/doi.org\/10.1038\/s41591-018-0019-5","journal-title":"Nat Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04318-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04318-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04318-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:49:40Z","timestamp":1775490580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04318-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4318"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04318-9","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}